Prolific Machines names Christina Perry CFO to drive Biopharmaceutical Growth with Optogenetics

• Christina Perry appointed CFO of Prolific Machines to drive growth and expand commercial reach.
• Perry brings 15 years of experience, including scaling Forge Biologics and raising over $300M.

Prolific Machines, a biotechnology company, announces Christina Perry as CFO. Perry will scale growth, enhance financial systems, and leverage her pharmaceutical and CDMO expertise to help expand Prolific’s commercial reach and achieve ambitious business goals. The appointment was made on February 13, 2025, in Emeryville, Calif.

Prolific Machines advances protein therapeutic development with its Photomolecular platform, combining optogenetic tools and closed-loop capabilities to control cellular functions. The Bay Area company aids biopharmaceutical and biotech firms in solving protein challenges and enhancing titer, quality, and consistency. Light-enabled receptor control reduces costs and shortens antibody therapeutic run times by eliminating growth factors.

Prolific Machines’ Co-Founder & CEO, Deniz Kent, PhD said, "We’re building a new toolkit to control biology that offers biotechnology and biopharmaceutical companies unprecedented control over their processes. As we prepare to announce even more opportunities to leverage our technology in the coming months, we couldn’t be more thrilled to welcome Christina to Prolific as our CFO, Her deep biopharmaceutical expertise and acumen for developing winning businesses will be paramount to our path forward as we prepare to share more exciting news in the months ahead.”

Before joining Prolific, Perry spent four years at Forge Biologics, a viral vector gene therapy company, where she built and scaled finance, accounting, and investor relations functions. She helped raise over $300M and expanded the company from 7 to 350 employees. Perry has expertise in complex legal structures, equity, and debt financings. With 15 years of experience across public and private companies, she specializes in scaling operations. She began her career at Deloitte as a CPA and holds a BBA from the University of Notre Dame and a Master of Accountancy from Miami University. In 2023, she was named a Woman of Influence by Columbus Business First.

Prolific Machines’ CFO Christina Perry said, “I have dedicated my career to building winning propositions through leading strategic fundraising, operational programs, and driving business growth. When this opportunity came along, it so perfectly married my biopharmaceutical expertise and passion, and I couldn’t be more excited to help Prolific achieve its mission and business goals.”